All articles by Phillip Broadwith
-
OpinionA unifying force for African medicines
The new African Medicines Agency is hugely important but faces significant challenges
-
OpinionChanging the rules of global chemicals trade
Chemical dumping claims reflect US and China’s focus on national interests ahead of global markets
-
OpinionInhaler propellant switch is worth the effort
Memories of a year spent testing new inhaler valve designs
-
BusinessUS judge to approve Purdue’s opioid bankruptcy deal
Settlement allows for future lawsuits against Sackler family owners
-
OpinionA robotic helping hand
Mechanical labmates are making huge progress, but there are still big challenges to overcome
-
BusinessPfizer wins bidding war for Metsera and its weight-loss drugs
US firm matched Novo Nordisk’s rival bid and had backing of competition regulator
-
BusinessPfizer and Novo Nordisk’s battle over Metsera
Lawsuits fly in bidding war over developer of next generation weight loss drugs
-
OpinionSpin-out support is stretched thin
University entrepreneurs need more consistent help to bridge the gap betweeen ideas and businesses
-
OpinionGoing round in circles over skills
Closing skills gaps in key professional groups requires collaboration between government, industry and educators
-
BusinessAt least 16 dead in factory and chemical warehouse fire in Bangladesh
Smoke and gas from chemical fire trapped and killed factory workers
-
-
OpinionTrump steps up pharma tariff threat
Taxing branded drug imports could hit biotech innovators hardest
-
OpinionA global petrochemical shift
China’s rapid capacity expansion fuels global oversupply, leading plant closures in Europe and elsewhere
-
BusinessFatal incidents at chemical plants in the US, India and Norway
Hydrogen and acid explosions, a fluorochemicals plant gas leak and a heavy lifting incident claimed at least four lives
-
OpinionIs UK pharma really ‘uninvestable’?
Merck & Co, AstraZeneca (AZ) and Eli Lilly pulling UK projects highlights the precarious position of the country’s life sciences industry
-
BusinessTwo workers killed in fire at fertiliser plant in Gujarat, India
A second fire the same day in Gujarat was tackled without casualties
-
OpinionUK biofuels burning out
With UK plants facing closure, what are the options and issues around different renewable fuels?
-
OpinionDeadly fentanyl contamination exposes drug safety challenges
Bacterial contamination in medical fentanyl has killed at least 51 people in Argentina, highlighting pressures on generic drugmakers
-
BusinessWill oral weight loss drugs challenge injectables?
Pills may offer convenience for manufacturers, but it’s not clear they will overtake existing drugs
-
OpinionCheap virgin plastic limits recycling potential
Global plastic treaty negotiations risk being derailed by minority opposed to production caps